Your session is about to expire
← Back to Search
Behavioral Intervention
essentiALZ for Knowledge, Attitudes, and Practices (KAP)
N/A
Waitlist Available
Led By Sheryl Zimmerman, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be followed for the duration of the intervention and 6 additional months after the intervention ends, an expected average of 8 months
Awards & highlights
Study Summary
This trial will compare two different training models for dementia care in assisted living facilities: one with essentiALZ training and the other with essentiALZ training + Project ECHO. The goal is
Who is the study for?
This trial is for direct care staff in assisted living facilities. It aims to improve dementia care by enhancing staff knowledge and practices, as well as the wellbeing of staff, residents, and their families. Participants will be involved in data collection over a 6-month period.Check my eligibility
What is being tested?
The study compares two training models: essentiALZ alone, and essentiALZ combined with Project ECHO against a waitlist control group. The goal is to see which model better improves dementia care workforce skills.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience changes in workload or stress levels due to new training procedures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ participants will be followed for the duration of the intervention and 6 additional months after the intervention ends, an expected average of 8 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be followed for the duration of the intervention and 6 additional months after the intervention ends, an expected average of 8 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Score Over Time of Dementia Attitude Scale - Short Form (DAS-6)
Change in Score Over Time of Sense of Competence in Dementia Care (SCIDS)
Change in Score Over Time of Staff Experience of Working with Residents with Dementia Questionnaire - Care Organization, Satisfactory Contact with the Patient, and Satisfaction with the Expectations of Others Subscales (SEWDRQ)
Secondary outcome measures
Change in Score Over Time of Emotional Burnout
Change in Score Over Time of Feeling Valued
Change in Score Over Time of Intention to Leave
+2 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: essentiALZ + ECHOExperimental Treatment2 Interventions
Communities randomized to this arm will receive the essentiALZ training: a web-based training taken by AL staff that contains three hours of self-paced content separated into five modules, plus a final review. Modules include: 1) Alzheimer's disease and dementia; 2) person-centered care; 3) assessment and care planning; 4) activities of daily living; and 5) behaviors and communication. Staff will be encouraged to take the training over the course of four weeks. Additionally, they will receive access to Project ECHO. ECHO is a virtual tele-mentoring model grounded in case-based learning. It includes six weekly one-hour sessions of didactic and discussive learning. The first five sessions will reflect the content of the five essentiALZ modules, and the final session will address maintenance. ECHO sessions are group sessions that will be conducted via Zoom.
Group II: essentiALZExperimental Treatment1 Intervention
Communities randomized to this arm will receive the essentiALZ training: a web-based training taken by AL staff that contains three hours of self-paced content separated into five modules, plus a final review. Modules include: 1) Alzheimer's disease and dementia; 2) person-centered care; 3) assessment and care planning; 4) activities of daily living; and 5) behaviors and communication. Staff will be encouraged to take the training over the course of four weeks.
Group III: No InterventionActive Control1 Intervention
Standard care will be provided.
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,189,061 Total Patients Enrolled
Alzheimer's AssociationOTHER
91 Previous Clinical Trials
39,074 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,676 Previous Clinical Trials
28,019,735 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any ongoing efforts to enroll patients in this current medical study?
"As per clinicaltrials.gov, the current trial is not actively seeking participants. Its initial posting was on May 1st, 2024, with the latest update made on January 24th of the same year. Although recruitment for this specific trial has ceased, there are currently 626 other trials open for patient enrollment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger